Reversible and Tunable Transcriptional Control for Functional Genomics. Aspergillus niger is a prolific cell factory, yet many of its most critical industrial traits are governed by essential genes that cannot be easily studied through traditional knockout methods. CD Biosynsis provides professional Aspergillus niger CRISPRi (CRISPR Interference) Services, offering a non-cleaving, dCas9-based platform for targeted gene silencing. By utilizing "dead" Cas9 fused with transcriptional repressors, our system sterically blocks RNA polymerase to suppress gene expression, providing an indispensable tool for metabolic engineering and strain optimization.
Get a Technical QuoteOur CRISPRi platform is specifically optimized for the filamentous fungal architecture, enabling precise control over primary and secondary metabolism without altering the underlying DNA sequence. We provide flexible solutions for genes where traditional disruption is technically prohibitive.
| Service Tier | Technical Focus | Primary Application | Strategic Value |
|---|---|---|---|
| Essential Gene Silencing | dCas9-mediated knockdown | Functional genomics & Growth study | Studies genes where KO is lethal |
| Multiplexed Pathway Repression | Multi-sgRNA interference | Citric acid optimization | Redirects flux by silencing multiple shunts |
| Inducible Gene Repression | Chemically regulated dCas9 | Dynamic metabolic flux control | Decouples growth from production |
| Secondary Metabolite Tuning | BGC silencing | Natural product discovery & Safety | Suppresses toxins or unwanted pigments |
| Microbial Interaction Profiling | Targeted signal molecule silencing | Fungal-Bacterial ecology research | Identifies keys to symbiotic performance |
1. Bioinformatic Design
2. System Assembly
3. Strain Transformation
4. Phenotypic Profiling
Identification of optimal repression windows and design of high-potency sgRNAs tailored for target fungal promoters.
Technical project feasibility study and Mutual NDA signing.
Construction of dCas9-repressor fusion expression cassettes and specialized sgRNA delivery vectors for Aspergillus niger.
Verification of dCas9 expression levels across different fungal growth phases.
Delivery of the CRISPRi machinery via protoplast-mediated or Agrobacterium-mediated transformation (AMT).
Selection of stable transformants through rigorous screening protocols.
Quantitative assessment of gene repression via RT-qPCR, followed by evaluation of growth kinetics and metabolite secretion.
Final delivery of repressed strains and comprehensive validation characterization dossiers.
We benchmark our transcriptional repression against landmark research to deliver superior functional genomic results.
Investigating gene function in strains lacking traditional structures requires innovative tools. Technical benchmarks implemented CRISPRi in the aconidial A. niger SH2 strain. By silencing the Dac1 gene and GlcNAc metabolic pathway, researchers validated their roles in forming spore-like structures, proving CRISPRi is vital for genetic verification in difficult industrial strains.
(Reference: Yu et al., 2022)
To maximize yields, competing pathways must be suppressed without compromising viability. Recent research utilized a multiplexed CRISPRi platform to simultaneously silence genes encoding inhibitory enzymes and competitive shunts like glycerol metabolism. Unlike permanent knockouts, this tunable repression avoids growth defects for large-scale bioreactor optimization.
(Reference: Aspergillus niger Citric Acid Regulation, 2023)
Understanding the chemical language of microbes is essential for biocontrol. Technical projects utilized CRISPRi to silence biosynthetic gene clusters (BGCs) responsible for mycotoxins in A. niger. By suppressing these compounds, researchers studied their role as signaling molecules in fungal-bacterial interactions, gaining insights into fungal communication in ecosystems.
(Reference: Aspergillus niger Fungal-Bacterial Interaction, 2025)
Ready to leverage tunable gene repression for your industrial strains?
Contact Us1. How does CRISPRi differ from RNAi in Aspergillus niger?
CRISPRi acts at the DNA level (transcriptional interference), whereas RNAi acts at the RNA level. CRISPRi often provides more robust and consistent silencing in filamentous fungi compared to variable RNAi efficiency.
2. Can I control the timing of gene repression during fermentation?
Yes. By using inducible promoters (such as tet-on or alcA systems) to drive dCas9 expression, you can trigger gene silencing at specific time points during the fermentation process.
3. What is the typical knockdown efficiency of this system?
Repression levels typically range from 60% to over 95%, depending on the target gene, the position of the sgRNA, and the strength of the fungal promoter used.
4. Does CRISPRi leave a permanent modification on the host genome?
No. CRISPRi is an interference system. If the dCas9/sgRNA expression is stopped or the plasmid is removed, the target gene can return to its original expression state.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.